PATENT CLAIM ANALYSIS

Application Number: 16246380
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "259000"]

Abstract:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R 1 , R 2 , R 3 , R 4 , R 5 , and n are as defined herein.

Claim (Index 2):
The compound or a pharmaceutically acceptable salt thereof, according to  claim 1 , wherein:\n each R 3A  is independently selected from: halogen, CN, \u2014(O) m \u2014(C 1 -C 4  alkyl substituted with 0-1 R 3B ), C 1 -C 4  haloalkyl, C 1 -C 4  haloalkoxy, R 3C , \u2014C(\u2550O)R 3D , NR 3E R 3F , \u2014C(\u2550O)NR 3E R 3F , \u2014S(\u2550O) 2 R 3D , \u2014S(\u2550O) 2 NHR 3F , \u2014NHS(\u2550O) 2 (C 1 -C 4  alkyl), \u2014O\u2014C 3 -C 6  cycloalkyl, and R a  is independently selected from: H, \u2192O, C 1 -C 4  alkyl substituted with 0-1 R b , \u2014C(\u2550O)H, \u2014C(\u2550O)(C 1 -C 4  alkyl), \u2014CO 2 (C 1 -C 4  alkyl), and C 3 -C 6  cycloalkyl; R 4  is H; m is independently selected from 0 and 1; and n is 0.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.27907
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14977273', '15538348', '16311575', '16311621', '16012468']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7933772749984686
- 35 USC 102 Novelty (BERT): 0.6087072031681164
- Combined Prediction Score: 0.7749102678154334
- Mean Citation Score: 448.49072400000006
- Max Citation Score: 509.5315
- Similarity Product: 506.8109459916056

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test